Tuesday, 24 February 2026

Novo Nordisk Stock Drops After Obesity Drug Trails Lilly’s Zepbound in Trial

 Novo Nordisk Shares Fall After Obesity Drug Trails Lilly Rival

#BreakingNews, #NovoNordisk, #EliLilly, #Zepbound, #Wegovy, #ObesityDrugs, #PharmaNews, #Biotech, #GLP1, #StockMarket


🚨 Breaking News: Novo Nordisk Stock Slides After Obesity Drug Misses Rival — Can It Catch Up to Lilly?

Breaking News 🚨 Shares of Novo Nordisk dropped sharply after trial data showed its next-generation obesity drug underperformed Eli Lilly’s blockbuster treatment. Why it matters: the $100B weight-loss market is heating up — and leadership may be shifting.

Click here 💻 Download Free Softwares 2026 | Best Tools for Windows & Mac – 100% Safe & Updated!**



📰 What Happened?

Novo Nordisk released late-stage trial results showing its experimental obesity drug CagriSema helped patients lose about 23% of their body weight over 84 weeks.

However, Eli Lilly’s competing drug Zepbound achieved roughly 25% weight loss in a comparable study — a difference analysts say could significantly impact market share.

Following the data release, Novo’s shares fell as investors questioned the drug’s commercial appeal.

Click here  🆓 Free Software Hub | Download Best Apps for PC, Editing, Gaming & More 💻✨**




🧩 Why This Matters

  • 💊 The obesity drug market is one of the fastest-growing in pharma

  • 💰 Billions in future revenue are at stake

  • 📈 Market leadership could determine long-term dominance

  • 🏥 Patients and insurers often choose the most effective option

Even small differences in weight-loss results can translate into major competitive advantages.

Click here 💾 Must-Have Free Softwares 2026 | Boost Productivity & Save Money Instantly! 💡**




💬 Analyst Reaction

BMO analyst Evan Seigerman wrote:

“We struggle to identify a reason why a patient would be prescribed CagriSema instead of Zepbound.”

JPMorgan analyst Chris Schott added that the results may make it difficult for Novo’s drug to gain market share, reinforcing Lilly’s position as a “clear market leader.”

 💥 Click Here to Get Free Softwares | Best Tools for Students & Professionals 2026 💼**



🏢 Novo’s Response

Novo CEO Mike Doustdar pushed back strongly against criticism:

“To say it’s obsolete is quite belittling a fantastic drug.”

Chief Scientific Officer Martin Holst Lange emphasized that the 23% reduction represents “clinically meaningful additive weight loss effects,” especially compared to drugs targeting GLP-1 alone.

CagriSema combines semaglutide (the active ingredient in Wegovy) with cagrilintide, a hormone that impacts appetite.




🧠 Simple Explanation for Readers

Two major drugmakers are racing to dominate weight-loss treatments. Lilly’s drug helped people lose slightly more weight in trials than Novo’s new treatment. Investors worry that doctors may favor the more effective option.

Novo argues its drug still delivers strong results and has long-term potential.

💥 “Discover This Secret Method Now!”


📊 Quick Comparison Snapshot

DrugCompanyWeight Loss (Trial)
ZepboundEli Lilly~25%
CagriSemaNovo Nordisk~23%

Note: Trial conditions vary and final approval decisions are pending.


🔬 What Happens Next?

✔ FDA decision on CagriSema expected late 2026
✔ Additional Phase 3 trial (REDEFINE 11) results expected 2027
✔ Higher-dose trials planned
✔ Lilly preparing next-gen drug targeting three gut hormones

Novo may also pursue acquisitions to strengthen its obesity pipeline.




📉 Impact on Economy & Markets

  • Novo shares declined following the announcement

  • Pharma investors rotating toward Lilly

  • Obesity drug market projected to exceed $100B annually

  • Insurance coverage battles may intensify

This competition is reshaping the pharmaceutical landscape.



🌍 Local Angle

In the U.S. and Europe, obesity rates remain high, driving massive demand for effective treatments. Insurance coverage decisions could influence which drug becomes the dominant option for patients.


🔎 Unique Insight

While a 2% difference may seem small, in a high-demand market where insurers and doctors seek the best clinical outcome, perception can shape dominance.

However, long-term safety data, dosing convenience, pricing, and supply chain reliability could ultimately determine the winner — not just headline weight-loss numbers.




❓ FAQ (Rich Results Ready)

Did Novo Nordisk’s obesity drug fail?

No. It showed strong results but slightly underperformed compared to Lilly’s Zepbound.

When will CagriSema be approved?

An FDA decision is expected in late 2026.

Is Zepbound the market leader?

Currently, analysts view it as the leading obesity treatment based on trial efficacy.

Why does a 2% difference matter?

In competitive drug markets, even small differences can impact doctor and insurer preferences.

Get Started in Seconds  Click Here!




🧲 Why This Matters

The obesity drug race is not just about weight loss — it’s about:

  • Healthcare spending

  • Insurance coverage

  • Pharmaceutical dominance

  • Long-term patient outcomes

This battle could define the next decade of biotech growth.

Get Started in Seconds  Click Here!




  • 📚 Original News Sources
  • CNBC Healthy Returns Newsletter

  • Company earnings call transcripts

  • Analyst notes from BMO & JPMorgan


🎯 “Claim Your Free Bonus Here!”




👀 See Also

  • FDA approval process explained

  • Insurance coverage for weight-loss drugs

  • Future of biotech mergers & acquisitions

Thursday, 20 November 2025

**Cassidy’s Life After CDC Vaccine Website Shift: “Life Is Lived Forward” 🌱**

 

#CassidyStory,#VaccineJourney,#LifeIsLivedForward,#PostVaccineLife

Republican members of Congress pushed back on Thursday — albeit lightly — on the Centers for Disease Control and Prevention’s controversial update to its webpage on vaccines and autism.

On Wednesday, the CDC changed its website, walking back assurances that vaccines do not cause autism and upending decades of work by the agency to combat misinformation about vaccines and autism.



The changed website specifically called out Sen. Bill Cassidy (R-La.), who cast a critical vote to confirm HHS Secretary Robert F. Kennedy Jr. after clashing with him over vaccines. Cassidy responded to the change Thursday with a strong endorsement of vaccines, but in an interview with Punchbowl News, declined to say he regrets voting to confirm Kennedy.



“Life is lived forward. What I have to do is do my best to reassure the American people that vaccines are safe,” Cassidy said. “We have to work against unfortunate attempts to undermine faith.”

Kennedy was a prominent figure in the anti-vaccine movement for years before becoming HHS secretary.




Cassidy, addressing reporters on Thursday, said he had spoken with Kennedy about the change but declined to give details about the conversation.

The website says: “The claim ‘vaccines do not cause autism’ is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism.”

Get Started in Seconds  Click Here!

 


It also includes an asterisked header that reads “Vaccines do not cause Autism,” and an accompanying reference to Cassidy: “The header ‘Vaccines do not cause autism’ has not been removed due to an agreement with the chair of the U.S. Senate Health, Education, Labor, and Pensions Committee that it would remain on the CDC website.”

🎯 “Claim Your Free Bonus Here!”



Cassidy said in February that he made agreements with Kennedy which led to his decision to confirm him, including that “CDC will not remove statements on their website pointing out that vaccines do not cause autism.”

💥 “Discover This Secret Method Now!”



“This is a common-sense update that brings CDC’s website in line with our commitment to transparency and gold standard science,” HHS spokesperson Andrew Nixon said in a statement. “As the updated page explains, the claim that ‘vaccines do not cause autism’ is not supported by comprehensive evidence, as studies to date have not definitively ruled out potential associations.”

👉 *Click Here to Try This Free Tool!*



Many large studies have found no link between vaccines and autism. Sandra Adamson Fryhofer, a trustee of the American Medical Association, which represents a large swath of America’s doctors, stressed that “extensive and rigorous studies consistently show that vaccines are safe.”

🔥 *Watch Now — Limited Offer!*



“Despite recent changes to the CDC website, an abundance of evidence from decades of scientific studies shows no link between vaccines and autism,” Fryhofer said in a statement.

Demetre Daskalakis, the former director of the CDC’s National Center for Immunization and Respiratory Diseases who resigned from the agency in August, criticized the website change in sharp terms Thursday.

### 🔐 **1️⃣ Best Free VPN Services 2025 | Browse Safely & Unlock Any Website 🌍✨**



“We cannot trust CDC anymore,” Daskalakis said. “It is being weaponized and weaponized more and more.” Other medical experts who raised concerns about the change included Democratic Governor of Hawaii Josh Green, a former emergency room physician. “Vaccines are not the problem. The problem is misinformation. The problem is getting too many people paranoid that good public health is going to cause them harm,” Green told POLITICO.

> “I recently found this amazing free app that tracks your calories — check it out here 🔗.”



In addition to Cassidy, some congressional Republicans seemed troubled by the CDC’s evolving stance toward vaccines. Sen. Susan Collins (R-Maine), the moderate appropriations chair who has occasionally been critical of Kennedy, told reporters she does not believe vaccines cause autism.

Click here 💻 Download Free Softwares 2025 | Best Tools for Windows & Mac – 100% Safe & Updated!**



Sen. John Barrasso (R-Wyo.) told reporters he had not seen the website change, but added: “I think vaccines are good. They’ve saved billions of lives.”With help from Robert King, Alice Miranda Ollstein and Amanda Friedman.

See more

👉 **Learn and Earn with Sir Khalid Butt – Master Online Skills & Start Earning Today! 💼🚀**


👉   🔥 **Turn Your Gaming Passion into Profit | Earn Cash Playing Games Online!**


👉   🏆 ** Best Ways to Earn Money Online in 2025 — Legit & Free Methods 💰**

kkk

👉   **Amazon Earning Secrets 2025 — How I Made $100+ Per Day Online! 🚀**

 

👉    💸 **Earn Real Money Online with AI Tools | Secrets to Passive Income in 2025!**

kkk

👉  **Start Earning Online Today | Build Your Shopify Store & Make Passive Income!**


👉   **"Earn Money Online Without Investment | Top Legit Ways to Make Money for Free in 2025"**

kkk

👉   ### **👀 Earn Money Online Watching Videos – No Investment Required! 💸 Start Earning Today!**


👉   **Earn Passive Income Watching Ads Online – No Investment Required! 🚀**

kkk

👉     🏆 ** Best Ways to Earn Money Online in 2025 — Legit & Free Methods 💰**


👉    🔥 Must-Have Favorites for Everyone! 🛍️ | Top-Rated Picks You’ll Love! ❤️

kkk

👉     ** Top-Rated Must-Haves 2025 | Best Home, Fashion, Tech, Beauty & Fitness Picks 🛒💖**

 👉     **💰 Smart Finance Hub 2025 | Money Tips, Investments & Earning Ideas 📈✨**

 

👉     # **🌿 Health & Wellness Hub | Best Nutrition, Weight Loss & Fitness Products 💪✨**

kkk

 👉     🎬✨ Ultimate Entertainment Hub | Movies, Music, TV & Celebrity Buzz 🌟

 

👉    **“🌸 Pregnancy Massage Benefits 🤰 | Relax & Rejuvenate 💆♀️”**

kkk

 👉     **📢 Sarkari Khabar 149: Latest Government Job Alerts, Results & Updates 2025 📰✨**

 

👉     **🚀📈 Expert Web Designer | Boost Sales with Fast & SEO-Optimized Websites 💻🌐**


 👉    🔥 Best Fiverr Gigs to Skyrocket Your Online Business 🚀 | Start Earning Now!

 

👉    **💕 Eternal Love Hub 2025 | Romantic Quotes, Date Ideas & Gifts for Couples 💍✨**

 

 

Thursday, 13 November 2025

Nolan Williams, Who Stimulated the Brain to Treat Depression, Dies at 43 💔🧠



Pioneering neuroscientist Nolan Williams—creator of the breakthrough SAINT brain-stimulation therapy for treatment-resistant depression—has died at 43. His legacy lives on. 🌟 #MentalHealth

A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the brain where depression originates.

Nolan Williams, an innovativeneuroscientist who developed a noninvasive brain-stimulation technique that has delivered unusually fast relief to people with treatment-resistant depression, died on Oct. 8 at his home in Northern California. He was 43.

💥 “Discover This Secret Method Now!”


His wife, Kristin Raj, said he died by suicide. Dr. Williams himself had struggled with depression, according to two of his colleagues.

Dr. Williams was hired by the Stanford University School of Medicine’s department of psychiatry and behavioral sciences in 2014. He soon started its Brain Stimulation Lab, where he focused on finding rapid-acting approaches to treat the dysfunctions underlying psychiatric illnesses, like depression, anxiety, obsessive-compulsive disorder and post-traumatic stress disorder, or PTSD.



In addition to stimulating the brain to deal with depression, he led studies of Special Operations veterans who had symptoms of PTSD and traumatic brain injury — among them anger, depression, anxiety and insomnia — and who had been treated in Mexico with the psychedelic drug ibogaine, which is illegal in the United States.



The nonprofit organization Veterans Exploring Treatment Solutions, or VETS, which collaborated with Dr. Williams on the ibogaine study, said in a statement after his death that “his research demonstrated what these veterans courageously believed: That healing was possible, that their suffering mattered, and that science could meet them in their darkest hour.”



Dr. Williams’s fascination with the brain’s circuitry surged when he was a student at the Medical University of South Carolina, where he learned about stimulating the brain to relieve depression that therapy and prescription drugs could not ease.

He went on to devise a fast-acting, high-tech therapy — called SAINT, for Stanford Accelerated Intelligent Neuromodulation Therapy — that targets the area in the brain where depression originates.




In clinical studies of about 400 people — by Stanford and Magnus Medical, a company that licensed its technology — about 80 percent saw their depression go into remission.

 

“We find a spot to stimulate the brain back into not being suicidal, not being depressed,” Dr. Williams said this year in an interview on “CBS Sunday Morning.”

 Get Started in Seconds  Click Here!

 


Depression is the leading cause of disability globally, according to the World Health Organization. It is variously treated with talk therapy, pharmaceutical medications and noninvasive therapies that use electrical currents or magnetic fields on the brain, like electroconvulsive therapy and transcranial magneticstimulation, or T.M.S.

Get Started in Seconds  Click Here!



How The Times decides who gets an obituary. There is no formula, scoring system or checklist in determining the news value of a life. We investigate, research and ask around before settling on our subjects. If you know of someone who might be a candidate for a Times obituary, please suggest it here.

Learn more about our process.

SAINT employs a magnetic resonance imaging scanner to pinpoint the region in the brain’s prefrontal cortex, which is responsible for depression.

Then a device, the stimulator, with an electromagnetic coil inside it, is placed on the scalp. When electric current is run through it, the coil produces a magnetic field that stimulates neurons with rapid, intermittent pulses in the targeted spot.

🎯 “Claim Your Free Bonus Here!”



Brandon Bentzley, a psychiatrist and the former director of innovation at the Brain Stimulation Lab, turned Dr. Williams’s concept into a technological reality. With Dr. Williams as a partner, he helped start Magnus, which has so far sold the stimulator and services to 15 clinics around the country.

 💥 “Discover This Secret Method Now!”



“We’ve seen people who had debilitating depressions for many decades and all of a sudden, they’re not depressed,” Dr. Bentzley said in an interview, adding that remission sometimes depends on whether a patient gets therapeutic support.

“They might relapse in months,” he said. “But we can re-treat them.”

The stimulation is provided over five days in 10 daily sessions, each lasting 10 minutes — a regimen of more stimulation in less time than other such treatments.

👉 *Click Here to Try This Free Tool!*



In SAINT’s first major study, published in 2021 in The American Journal of Psychiatry, 14 of 29 people received the treatment. Eleven of the 14, or 78.6 percent, experienced remission within four weeks, the study found; some needed as few as five days. On average, people felt better in 2.6 days.

 💥 Click Here to Get Free Softwares | Best Tools for Students & Professionals 2025 💼**



“The effects of SAINT look very promising for people with

treatment-resistant depression, but more work is needed to verify them,” said Mouhsin Shafi, an associate professor of neurology at Beth Israel Deaconess Medical Center and director of the Berenson-Allen Center for Noninvasive Brain Stimulation, both in Boston. “We need to understand more about how durable the effects are and how to extend them for a longer period of time.”

👉 *Click Here to Try This Free Tool!*



The Food and Drug Administration cleared SAINT for psychiatric treatment in 2022; Medicare covers it in hospitals; and some insurance companies cover it in private clinics. The cost for a one-week regimen can run from $18,000 to $36,000.

 🎯 “Claim Your Free Bonus Here!”



Side effects include headaches and short-lived pain at the stimulation site during treatment.

Nolan Ryan Williams — his father, a baseball fan, named him after the Hall of Fame pitcher Nolan Ryan — was born on June 25, 1982, in Bamberg, S.C., and grew up in Charleston. His father, Bryan, was a fisherman and carpenter. His mother, Ann (Hewitt) Williams, ran a day care center and later worked as a caterer.

👉 *Click Here to Try This Free Tool!*



Nolan, who attained a black belt in taekwondo at 18 and was a skilled kitesurfer, earned a bachelor’s degree in molecular biology from the College of Charleston in 2003.

After receiving his medical degree from the Medical University of South Carolina in 2008, he remained there for residencies in neurology and psychiatry as well as fellowships in clinical neuromodulation and human neuroscience with Mark George, a neurologist and psychiatrist who runs the university’s brain stimulation lab.

👉 *Click Here to Try This Free Tool!*



“Nolan started working in the lab when he was still an undergraduate and was enormously curious,” Dr. George, a pioneer in T.M.S. treatment for depression, said. “And once he was in medical school, he came after class or on weekends and summers to do research. He was always asking ‘why?’ questions and dreaming up the next step or two or three.”

💥 “Discover This Secret Method Now!”






Dr. George recalled Dr. Williams telling him while in his residency that he wanted to combine three ambitious steps — each of which had been studied — to create what became SAINT.

 🔥 *Watch Now — Limited Offer!*



“I said, ‘Nolan did I not teach you anything? You do one thing at a time in science,’ but he said, ‘I want to move us forward,’” Dr. George recalled.

Dr. Williams’s first step was to greatly accelerate the pace of magnetic pulses and condense the time span of treatment. The second involved using magnetic resonance imaging to accurately target the spot in the brain to stimulate. And the third was to have the M.R.I. measure brain atrophy and adjust the intensity of the brain stimulation to account for it.

“What he did was transformative,” Dr. George said.

 ### 🔐 **1️⃣ Best Free VPN Services 2025 | Browse Safely & Unlock Any Website 🌍✨**



Dr. Williams’s interest in the brain’s reaction to ibogaine led to a collaboration with VETS, which helps veterans get access to psychedelics to treat traumatic brain injuries. One of its founders, Marcus Capone, a retired member of the Navy SEALs, first took ibogaine in 2017 and had a remarkable recovery.

His wife, Amber Capone, who founded VETS with her husband, recalled the relief she felt when she met Dr. Williams in 2018 after being rejected by doctors, researchers and military leaders when she sought their help in validating the impact of ibogaine on veterans.

 > “I recently found this amazing free app that tracks your calories — check it out here 🔗.”



“I had been desperately trying to get anyone I could to listen to me,” she said in aninterview. “Nolan was the first person to listen and take me seriously.”

Dr. Williams designed a study in which 30 Special Operations veterans were tested and evaluated before and after they were treated at an ibogaine clinic in Mexico from 2021 to 2022. Ibogaine is an alkaloid derived from the bark of the African shrub iboga.

Click here 💻 Download Free Softwares 2025 | Best Tools for Windows & Mac – 100% Safe & Updated!**


The first of two studies, published in 2024 in the journal Nature Medicine, showed that a month after treatment, 83 percent of the veterans had achieved remission from PTSD, 73 percent had achieved remission from depression, and 86 percent had achieved remission from anxiety.

“These are the most dramatic drug effects I’ve ever captured in an observational study,” Dr. Williams told The New York Times in 2024. But, he added, “Without a greenlight to conduct studies from the F.D.A., you just can’t do the kind of randomized trials that are

the gold standard for clinical studies.”

Click here 🚀 Top 10 Free Software Websites 2025 | Get Premium Tools Without Paying a Cent! 🔥**



In addition to his wife, a clinical professor of psychiatry and behavioral sciences at Stanford who has treated patients with SAINT, Dr. Williams is survived by his mother; a daughter, Autumn; a son, Hendrix; and a brother, Kyle.

 Click here  🆓 Free Software Hub | Download Best Apps for PC, Editing, Gaming & More 💻✨**



Dr. George said that he had been aware of Dr. Williams’s own depression and had encouraged him to get help, but that he wasn’t certain if Dr. Williams was treated with SAINT.

He added: “I wonder if somewhere inside him he still harbored some stigma about depression. But these brain stimulation treatments combat the stigma.”

Click here 💾 Must-Have Free Softwares 2025 | Boost Productivity & Save Money Instantly! 💡**



If you are having thoughts of suicide, call or text 988 to reach the 988 Suicide and Crisis Lifeline or go to SpeakingOfSuicide.com/resources for a list of additional resources.

Richard Sandomir, an obituaries reporter, has been writing for The Times for more than three decades.

 

 See more


👉   🔥 **Turn Your Gaming Passion into Profit | Earn Cash Playing Games Online!**


👉   🏆 ** Best Ways to Earn Money Online in 2025 — Legit & Free Methods 💰**

kkk

👉   **Amazon Earning Secrets 2025 — How I Made $100+ Per Day Online! 🚀**

 

👉    💸 **Earn Real Money Online with AI Tools | Secrets to Passive Income in 2025!**

kkk

👉  **Start Earning Online Today | Build Your Shopify Store & Make Passive Income!**


👉   **"Earn Money Online Without Investment | Top Legit Ways to Make Money for Free in 2025"**

kkk

👉   ### **👀 Earn Money Online Watching Videos – No Investment Required! 💸 Start Earning Today!**


👉   **Earn Passive Income Watching Ads Online – No Investment Required! 🚀**

kkk

👉     🏆 ** Best Ways to Earn Money Online in 2025 — Legit & Free Methods 💰**


👉    🔥 Must-Have Favorites for Everyone! 🛍️ | Top-Rated Picks You’ll Love! ❤️

kkk

👉     ** Top-Rated Must-Haves 2025 | Best Home, Fashion, Tech, Beauty & Fitness Picks 🛒💖**

 👉     **💰 Smart Finance Hub 2025 | Money Tips, Investments & Earning Ideas 📈✨**

 

👉     # **🌿 Health & Wellness Hub | Best Nutrition, Weight Loss & Fitness Products 💪✨**

kkk

 👉     🎬✨ Ultimate Entertainment Hub | Movies, Music, TV & Celebrity Buzz 🌟

 

👉    **“🌸 Pregnancy Massage Benefits 🤰 | Relax & Rejuvenate 💆♀️”**

kkk

 👉     **📢 Sarkari Khabar 149: Latest Government Job Alerts, Results & Updates 2025 📰✨**

 

👉     **🚀📈 Expert Web Designer | Boost Sales with Fast & SEO-Optimized Websites 💻🌐**


 👉    🔥 Best Fiverr Gigs to Skyrocket Your Online Business 🚀 | Start Earning Now!

 

👉    **💕 Eternal Love Hub 2025 | Romantic Quotes, Date Ideas & Gifts for Couples 💍✨**

 

 

 

 

Novo Nordisk Stock Drops After Obesity Drug Trails Lilly’s Zepbound in Trial

  Novo Nordisk Shares Fall After Obesity Drug Trails Lilly Rival 🚨 Breaking News: Novo Nordisk Stock Slides After Obesity Drug Misses Rival...